Literature DB >> 23400328

IL-17A/F modulates fibrocyte functions in cooperation with CD40-mediated signaling.

Hisako Hayashi1, Akiko Kawakita, Shintaro Okazaki, Motoko Yasutomi, Hiroki Murai, Yusei Ohshima.   

Abstract

T helper 17 (Th17) cells that produce interleukin (IL)-17A and IL-17F have been found to participate in the development of bronchial asthma and bleomycin-induced pulmonary fibrosis. However, whether they play a causative role in the airway remodeling observed in these respiratory diseases remains unclear. Because fibrocytes are involved in tissue repair and fibrosis and are presumably precursors of lung fibroblasts and myofibroblasts, we examined the effects of IL-17A/F on fibrocyte functions. Both IL-17A and IL-17F enhanced fibrocytes' α-smooth muscle actin expression. Priming fibrocytes with IL-17A enhanced their CD40-mediated IL-6 production, whereas IL-17F-priming increased the CD40-mediated mRNA expression of collagen I, vascular endothelial growth factor, and angiogenin. CD4(+) T cells co-cultured with fibrocytes produced IL-17A, which was inhibited by blocking CD40 and CD40 ligand interactions. These findings suggest that cooperative interactions between fibrocytes and Th17 cells play an important role via CD40- and IL-17A/F-mediated signaling for collagen and proangiogenic factor production, which may lead to the extracellular matrix deposition and neovascularization seen in airway remodeling.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23400328     DOI: 10.1007/s10753-013-9609-z

Source DB:  PubMed          Journal:  Inflammation        ISSN: 0360-3997            Impact factor:   4.092


  38 in total

1.  IL-17 is increased in asthmatic airways and induces human bronchial fibroblasts to produce cytokines.

Authors:  S Molet; Q Hamid; F Davoine; E Nutku; R Taha; N Pagé; R Olivenstein; J Elias; J Chakir
Journal:  J Allergy Clin Immunol       Date:  2001-09       Impact factor: 10.793

2.  Airway remodeling-associated mediators in moderate to severe asthma: effect of steroids on TGF-beta, IL-11, IL-17, and type I and type III collagen expression.

Authors:  Jamila Chakir; Joanne Shannon; Sophie Molet; Motonori Fukakusa; Jack Elias; Michel Laviolette; Louis-Philippe Boulet; Qutayba Hamid
Journal:  J Allergy Clin Immunol       Date:  2003-06       Impact factor: 10.793

Review 3.  The bone marrow leaves its scar: new concepts in pulmonary fibrosis.

Authors:  Sarah E Dunsmore; Steven D Shapiro
Journal:  J Clin Invest       Date:  2004-01       Impact factor: 14.808

4.  TGF-beta driven lung fibrosis is macrophage dependent and blocked by Serum amyloid P.

Authors:  Lynne A Murray; Qingsheng Chen; Michael S Kramer; David P Hesson; Rochelle L Argentieri; Xueyang Peng; Mridu Gulati; Robert J Homer; Thomas Russell; Nico van Rooijen; Jack A Elias; Cory M Hogaboam; Erica L Herzog
Journal:  Int J Biochem Cell Biol       Date:  2010-10-29       Impact factor: 5.085

5.  Circulating peripheral blood fibrocytes in human fibrotic interstitial lung disease.

Authors:  Borna Mehrad; Marie D Burdick; David A Zisman; Michael P Keane; John A Belperio; Robert M Strieter
Journal:  Biochem Biophys Res Commun       Date:  2006-12-11       Impact factor: 3.575

6.  The peripheral blood fibrocyte is a potent antigen-presenting cell capable of priming naive T cells in situ.

Authors:  J Chesney; M Bacher; A Bender; R Bucala
Journal:  Proc Natl Acad Sci U S A       Date:  1997-06-10       Impact factor: 11.205

Review 7.  Circulating fibrocytes: collagen-secreting cells of the peripheral blood.

Authors:  Timothy E Quan; Shawn Cowper; Sou-Pan Wu; Linda K Bockenstedt; Richard Bucala
Journal:  Int J Biochem Cell Biol       Date:  2004-04       Impact factor: 5.085

8.  Identification of circulating fibrocytes as precursors of bronchial myofibroblasts in asthma.

Authors:  Matthias Schmidt; Guo Sun; Martin A Stacey; Luca Mori; Sabrina Mattoli
Journal:  J Immunol       Date:  2003-07-01       Impact factor: 5.422

Review 9.  Fibrocytes in lung disease.

Authors:  Brigitte N Gomperts; Robert M Strieter
Journal:  J Leukoc Biol       Date:  2007-06-05       Impact factor: 4.962

10.  Accelerated wound healing in leukocyte-specific, protein 1-deficient mouse is associated with increased infiltration of leukocytes and fibrocytes.

Authors:  JianFei Wang; Haiyan Jiao; Tara L Stewart; Megan V H Lyons; Heather A Shankowsky; Paul G Scott; Edward E Tredget
Journal:  J Leukoc Biol       Date:  2007-12       Impact factor: 4.962

View more
  15 in total

1.  Regulation of IL-17A and implications for TGF-β1 comodulation of airway smooth muscle remodeling in severe asthma.

Authors:  Jon M Evasovic; Cherie A Singer
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2019-02-27       Impact factor: 5.464

2.  IL-25 promotes Th2 immunity responses in airway inflammation of asthmatic mice via activation of dendritic cells.

Authors:  Li Hongjia; Zhang Caiqing; Lu Degan; Liu Fen; Wang Chao; Wu Jinxiang; Dong Liang
Journal:  Inflammation       Date:  2014-08       Impact factor: 4.092

3.  A comprehensive network map of IL-17A signaling pathway.

Authors:  D A B Rex; Shobha Dagamajalu; Mahesh Manjunath Gouda; G P Suchitha; Jaikanth Chanderasekaran; Rajesh Raju; T S Keshava Prasad; Yashodhar Prabhakar Bhandary
Journal:  J Cell Commun Signal       Date:  2022-07-15       Impact factor: 5.908

4.  Molecular Clustering Analysis of Blood Biomarkers in World Trade Center Exposed Community Members with Persistent Lower Respiratory Symptoms.

Authors:  Gabriele Grunig; Nedim Durmus; Yian Zhang; Yuting Lu; Sultan Pehlivan; Yuyan Wang; Kathleen Doo; Maria L Cotrina-Vidal; Roberta Goldring; Kenneth I Berger; Mengling Liu; Yongzhao Shao; Joan Reibman
Journal:  Int J Environ Res Public Health       Date:  2022-07-01       Impact factor: 4.614

Review 5.  IL-17 in the lung: the good, the bad, and the ugly.

Authors:  Stephen J Gurczynski; Bethany B Moore
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2017-08-31       Impact factor: 5.464

6.  Pathogenic TH17 inflammation is sustained in the lungs by conventional dendritic cells and Toll-like receptor 4 signaling.

Authors:  Karim H Shalaby; Miranda R Lyons-Cohen; Gregory S Whitehead; Seddon Y Thomas; Immo Prinz; Hideki Nakano; Donald N Cook
Journal:  J Allergy Clin Immunol       Date:  2017-11-14       Impact factor: 10.793

7.  High IL-17E and low IL-17C dermal expression identifies a fibrosis-specific motif common to morphea and systemic sclerosis.

Authors:  Paola Adele Lonati; Nicolò Costantino Brembilla; Elisa Montanari; Lionel Fontao; Armando Gabrielli; Serena Vettori; Gabriele Valentini; Emmanuel Laffitte; Gurkan Kaya; Pier-Luigi Meroni; Carlo Chizzolini
Journal:  PLoS One       Date:  2014-08-19       Impact factor: 3.240

Review 8.  Biological Therapies of Severe Asthma and Their Possible Effects on Airway Remodeling.

Authors:  Grzegorz Kardas; Piotr Kuna; Michał Panek
Journal:  Front Immunol       Date:  2020-06-18       Impact factor: 7.561

9.  Aberrant expression of interleukin-23-regulated miRNAs in T cells from patients with ankylosing spondylitis.

Authors:  Ning-Sheng Lai; Hui-Chun Yu; Chien-Hsueh Tung; Kuang-Yung Huang; Hsien-Bin Huang; Ming-Chi Lu
Journal:  Arthritis Res Ther       Date:  2018-11-21       Impact factor: 5.156

10.  IL-33 enhanced the proliferation and constitutive production of IL-13 and IL-5 by fibrocytes.

Authors:  Hisako Hayashi; Akiko Kawakita; Shintaro Okazaki; Hiroki Murai; Motoko Yasutomi; Yusei Ohshima
Journal:  Biomed Res Int       Date:  2014-04-13       Impact factor: 3.411

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.